Patient with colorectal cancer with heterogeneous KRAS molecular status responding to cetuximab-based chemotherapy.
Mancuso
Andrea
A
San Camillo-Forlanini Hospital, Rome, Italy.
Sollami
Rossella
R
Recine
Federica
F
Cerbone
Linda
L
Macciomei
Maria Cristina
MC
Leone
Alvaro
A
D000230:Adenocarcinoma / Q000235:genetics / Q000628:therapy*; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000235:genetics / Q000628:therapy*; D006801:Humans; D008297:Male; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000235:genetics*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins; D000068818:Cetuximab